Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation

被引：0
|
作者：
Muzio, Sofia [1 ]
Artaza, Gonzalo [2 ]
Benitez Hidalgo, Olga [2 ]
Cortina, Vicente [1 ]
Campoy, Desiree [2 ]
Beas, Francisco [1 ]
Bosch, Marc [1 ]
Serra, Marina [1 ]
Bosch, Francesc [1 ,3 ]
Olivera, Pavel E. [2 ,3 ]
机构：
[1] Vall dHebron Univ Hosp, Dept Hematol, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Dept Hematol, Thrombosis & Hemostasis Unit, Barcelona, Spain
[3] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol VHIO, Expt Hematol, Barcelona, Spain
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190604
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Nishimura, Marin
    Hsu, Jonathan C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (01): : 131 - 140
  • [2] Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States
    Siontis, Konstantinos C.
    Zhang, Xiaosong
    Eckard, Ashley
    Bhave, Nicole
    Schaubel, Douglas E.
    He, Kevin
    Tilea, Anca
    Stack, Austin G.
    Balkrishnan, Rajesh
    Yao, Xiaoxi
    Noseworthy, Peter A.
    Shah, Nilay D.
    Saran, Rajiv
    Nallamothu, Brahmajee K.
    [J]. CIRCULATION, 2018, 138 (15) : 1519 - 1529
  • [3] APIXABAN FOR STROKE PREVENTION IN END-STAGE KIDNEY DISEASE PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS
    Abdullah, Hafez M.
    Ullah, Waqas
    Jafar, Munnam
    Gowda, Smitha Narayana
    Alraies, M. Chadi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 514 - 514
  • [4] Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
    Watanabe, Hiroshi
    Minamino, Tohru
    [J]. INTERNAL MEDICINE, 2018, 57 (16) : 2285 - 2286
  • [5] Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned
    Benz, Alexander P. P.
    Eikelboom, John W. W.
    [J]. CIRCULATION, 2022, 146 (23) : 1746 - 1748
  • [6] Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study
    Simonetta Genovesi
    Paola Rebora
    Maurizio Gallieni
    Andrea Stella
    Fabio Badiali
    Ferruccio Conte
    Sonia Pasquali
    Silvio Bertoli
    Patrizia Ondei
    Giuseppe Bonforte
    Claudio Pozzi
    Emanuela Rossi
    Maria Grazia Valsecchi
    Antonio Santoro
    [J]. Journal of Nephrology, 2017, 30 : 573 - 581
  • [7] Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study
    Genovesi, Simonetta
    Rebora, Paola
    Gallieni, Maurizio
    Stella, Andrea
    Badiali, Fabio
    Conte, Ferruccio
    Pasquali, Sonia
    Bertoli, Silvio
    Ondei, Patrizia
    Bonforte, Giuseppe
    Pozzi, Claudio
    Rossi, Emanuela
    Valsecchi, Maria Grazia
    Santoro, Antonio
    [J]. JOURNAL OF NEPHROLOGY, 2017, 30 (04) : 573 - 581
  • [8] Safety of Nonvitamin K Antagonists Compared with Warfarin in Patients with Atrial Fibrillation and End-Stage Kidney Disease
    Pinner, Nathan A.
    Osmonson, Alyssa J.
    Starr, Jessica A.
    [J]. SOUTHERN MEDICAL JOURNAL, 2022, 115 (10) : 794 - 798
  • [9] Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
    Hu, Austin
    Niu, Jingbo
    Winkelmayer, Wolfgang C.
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (06) : 618 - 628
  • [10] Stroke and Bleeding in Patients with Atrial Fibrillation and End-Stage Renal Disease Treated with Apixaban Versus Warfarin
    Lara, Joao Manoel Da Silveira
    Dourado, Claudia
    [J]. BLOOD, 2023, 142
12345